Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurology Vol. 263; no. 7; pp. 1323 - 1331
Main Authors Balk, Lisanne J., Cruz-Herranz, Andrés, Albrecht, Philipp, Arnow, Sam, Gelfand, Jeffrey M., Tewarie, Prejaas, Killestein, Joep, Uitdehaag, Bernard M. J., Petzold, Axel, Green, Ari J.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2016
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell–inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1–45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (−1.1 µm, 95 % CI 1.4–0.7, p  < 0.001) and mGCIPL (−1.1 µm, 95 % CI −1.4 to −0.8, p  < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (−0.03 µm, 95 % CI −0.2 to 0.2, p  = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
AbstractList The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell–inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1–45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (−1.1 µm, 95 % CI 1.4–0.7, p  < 0.001) and mGCIPL (−1.1 µm, 95 % CI −1.4 to −0.8, p  < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (−0.03 µm, 95 % CI −0.2 to 0.2, p  = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 mu m, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 mu m, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 mu m, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.
Author Cruz-Herranz, Andrés
Petzold, Axel
Arnow, Sam
Tewarie, Prejaas
Killestein, Joep
Gelfand, Jeffrey M.
Green, Ari J.
Balk, Lisanne J.
Albrecht, Philipp
Uitdehaag, Bernard M. J.
Author_xml – sequence: 1
  givenname: Lisanne J.
  surname: Balk
  fullname: Balk, Lisanne J.
  email: l.balk@vumc.nl
  organization: Department of Neurology, MS Centre, VU University Medical Center
– sequence: 2
  givenname: Andrés
  surname: Cruz-Herranz
  fullname: Cruz-Herranz, Andrés
  organization: Department of Neurology, University of California San Francisco
– sequence: 3
  givenname: Philipp
  surname: Albrecht
  fullname: Albrecht, Philipp
  organization: Department of Neurology, Heinrich-Heine University
– sequence: 4
  givenname: Sam
  surname: Arnow
  fullname: Arnow, Sam
  organization: Department of Neurology, University of California San Francisco
– sequence: 5
  givenname: Jeffrey M.
  surname: Gelfand
  fullname: Gelfand, Jeffrey M.
  organization: Department of Neurology, University of California San Francisco
– sequence: 6
  givenname: Prejaas
  surname: Tewarie
  fullname: Tewarie, Prejaas
  organization: Department of Neurology, MS Centre, VU University Medical Center
– sequence: 7
  givenname: Joep
  surname: Killestein
  fullname: Killestein, Joep
  organization: Department of Neurology, MS Centre, VU University Medical Center
– sequence: 8
  givenname: Bernard M. J.
  surname: Uitdehaag
  fullname: Uitdehaag, Bernard M. J.
  organization: Department of Neurology, MS Centre, VU University Medical Center
– sequence: 9
  givenname: Axel
  surname: Petzold
  fullname: Petzold, Axel
  organization: Department of Neurology, MS Centre, VU University Medical Center, Moorfields Eye Hospital, UCL Institute of Neurology
– sequence: 10
  givenname: Ari J.
  surname: Green
  fullname: Green, Ari J.
  organization: Department of Neurology, University of California San Francisco
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27142714$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtP3DAUha0KVGZof0A3VSQ23QSuE8ePLpDQiKeoWHS6tjyOPTXK2NROKubf48xABUhULCz76n7n6PqeKdrxwRuEvmA4xADsKAEQ3JSAaclxxcr1BzTBpK5KTBqxgyZQEyibuiF7aJrSLQDw3PiI9iqGyXgm6GruVs4vi2CLaHrnVVd4M8QwPpRvC3W_eXYhpcL54sfP74XKlV-6fmg3-M1sXqRcrD-hXau6ZD4_3vvo19npfHZRXt-cX85OrkvdQN2XiwVWXAkramYr3dSWWWMIsZoTzrkmgraMW0brtuILaDgmynIBBogArlte76Pjre_dsFiZVhvfR9XJu-hWKq5lUE6-7Hj3Wy7DX0lEJTCDbPDt0SCGP4NJvVy5pE3XKW_CkCTmwFnFCKXvQfMmqWhYRg9eobdhiHlDGwooUEpG6uvz4f9N_ZRIBtgW0DHvPBortetV78L4F9dJDHLMXm6zlzl7OWYv11mJXymfzP-nqbaalFm_NPHZ0G-KHgBYqL_P
CitedBy_id crossref_primary_10_1371_journal_pone_0187600
crossref_primary_10_1371_journal_pone_0216410
crossref_primary_10_1002_brb3_1032
crossref_primary_10_1016_j_msard_2022_103761
crossref_primary_10_3389_fnins_2021_692599
crossref_primary_10_1016_S1474_4422_17_30278_8
crossref_primary_10_3390_brainsci14010036
crossref_primary_10_1097_WNO_0000000000001280
crossref_primary_10_1136_jnnp_2024_334801
crossref_primary_10_1016_j_jns_2018_01_020
crossref_primary_10_1177_17562864211003478
crossref_primary_10_1016_S1474_4422_21_00218_0
crossref_primary_10_1016_j_msard_2018_03_007
crossref_primary_10_1007_s40263_018_0521_9
crossref_primary_10_1016_j_jns_2021_117552
crossref_primary_10_4103_tjo_tjo_76_20
crossref_primary_10_1212_NXI_0000000000200269
crossref_primary_10_1136_bmjno_2023_000560
crossref_primary_10_1007_s11940_017_0452_7
crossref_primary_10_3389_fneur_2020_628542
crossref_primary_10_1016_j_jns_2023_120552
crossref_primary_10_1212_NXI_0000000000001051
crossref_primary_10_1002_acn3_51473
crossref_primary_10_1016_j_compbiomed_2020_104165
crossref_primary_10_1111_cns_70225
crossref_primary_10_1177_1352458518817987
crossref_primary_10_1177_1352458516677590
crossref_primary_10_1097_WNO_0000000000000802
crossref_primary_10_1002_ana_26440
crossref_primary_10_1007_s00115_022_01302_5
crossref_primary_10_1111_ene_16529
crossref_primary_10_1167_tvst_8_3_34
crossref_primary_10_1371_journal_pone_0289495
crossref_primary_10_1097_WCO_0000000000000604
crossref_primary_10_1159_000510116
crossref_primary_10_1186_s12886_021_02158_0
crossref_primary_10_1016_j_msard_2025_106259
crossref_primary_10_1212_WNL_0000000000200977
crossref_primary_10_1007_s00415_018_8988_3
crossref_primary_10_1212_NXI_0000000000000671
crossref_primary_10_1007_s10633_021_09855_7
crossref_primary_10_1080_01616412_2020_1761174
crossref_primary_10_1007_s11940_018_0493_6
crossref_primary_10_2217_nmt_2018_0011
crossref_primary_10_1097_IAE_0000000000002043
crossref_primary_10_3389_fneur_2021_615790
crossref_primary_10_1038_s41598_024_53830_6
crossref_primary_10_1177_17562864221118731
crossref_primary_10_1016_j_msard_2018_02_010
crossref_primary_10_1097_WNO_0000000000002244
crossref_primary_10_1038_s41467_024_49309_7
crossref_primary_10_1016_j_jns_2023_120847
crossref_primary_10_1007_s00415_021_10469_x
crossref_primary_10_1038_s41598_022_06821_4
crossref_primary_10_1016_j_msard_2022_104255
crossref_primary_10_1016_j_compbiomed_2021_104416
crossref_primary_10_1080_00207454_2019_1576660
crossref_primary_10_1212_NXI_0000000000000572
crossref_primary_10_1038_s41598_021_86061_0
crossref_primary_10_1111_epi_18139
crossref_primary_10_1371_journal_pone_0288581
crossref_primary_10_1007_s00415_016_8271_4
crossref_primary_10_3390_jcm14061998
crossref_primary_10_1177_1352458517694090
crossref_primary_10_1186_s41983_020_00204_0
crossref_primary_10_1007_s10072_024_07664_9
crossref_primary_10_1515_biol_2022_0866
crossref_primary_10_1097_WCO_0000000000000418
crossref_primary_10_1007_s00347_022_01728_x
crossref_primary_10_1212_NXI_0000000000000449
crossref_primary_10_1016_j_msard_2019_101414
crossref_primary_10_1002_brb3_1467
crossref_primary_10_1016_j_compbiomed_2021_104822
crossref_primary_10_1080_23808993_2017_1393315
crossref_primary_10_3389_fneur_2019_01117
crossref_primary_10_1038_s41598_022_24312_4
crossref_primary_10_1136_jnnp_2023_331183
crossref_primary_10_1186_s12974_019_1521_5
crossref_primary_10_1007_s00415_022_11449_5
crossref_primary_10_1212_WNL_0000000000201223
crossref_primary_10_1212_WNL_0000000000006189
crossref_primary_10_1155_2021_5573839
crossref_primary_10_1080_14737175_2019_1559051
crossref_primary_10_3389_fneur_2017_00675
crossref_primary_10_1093_braincomms_fcac065
crossref_primary_10_1073_pnas_2115973119
crossref_primary_10_1177_2040622319882205
crossref_primary_10_1136_jnnp_2021_327468
crossref_primary_10_1212_WNL_0000000000011928
crossref_primary_10_1212_NXI_0000000000001155
crossref_primary_10_3390_ijms241612872
crossref_primary_10_1136_jnnp_2023_332332
crossref_primary_10_1097_WNO_0000000000000662
crossref_primary_10_24875_RMO_M18000062
crossref_primary_10_1007_s10072_020_04431_4
crossref_primary_10_1093_brain_awz188
crossref_primary_10_1002_ana_25738
crossref_primary_10_1177_11206721221112803
crossref_primary_10_1177_1352458517739136
crossref_primary_10_1001_jamaneurol_2018_1011
crossref_primary_10_1177_1352458519872751
crossref_primary_10_3390_jcm8112022
crossref_primary_10_1186_s12974_019_1583_4
Cites_doi 10.1136/jnnp-2013-306902
10.1016/S1474-4422(12)70213-2
10.1212/01.wnl.0000260612.51849.ed
10.1007/978-1-4471-6380-0_14
10.1146/annurev.neuro.30.051606.094313
10.1002/ana.21436
10.1016/j.jns.2009.02.354
10.1093/brain/awh126
10.1177/1352458509106510
10.1111/ene.12532
10.1177/1352458514523498
10.1007/s00415-010-5467-x
10.1111/ene.12070
10.1167/iovs.13-12073
10.1001/jamaneurol.2013.573
10.1177/1352458514542862
10.1093/brain/awq080
10.1167/iovs.13-12912
10.1177/1352458513489757
10.1038/nrneurol.2014.108
10.1177/1352458514538110
10.1212/WNL.46.4.907
10.1002/ana.24351
10.1177/1352458512439237
10.1212/01.WNL.0000055926.69643.03
10.1002/ana.24030
10.1002/ana.20575
10.1371/journal.pone.0030922
10.1212/WNL.33.11.1444
10.1093/brain/aws098
10.1093/brain/awr264
10.1016/S1474-4422(10)70168-X
10.1097/WNO.0b013e318238937f
10.1371/journal.pone.0036847
10.1002/ana.21423
10.1002/ana.24487
10.1002/ana.22005
10.1155/2013/134858
ContentType Journal Article
Copyright The Author(s) 2016
Springer-Verlag Berlin Heidelberg 2016
Copyright_xml – notice: The Author(s) 2016
– notice: Springer-Verlag Berlin Heidelberg 2016
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s00415-016-8127-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Proquest Health and Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Middle East (New)
MEDLINE - Academic
MEDLINE
Neurosciences Abstracts

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1459
EndPage 1331
ExternalDocumentID PMC4929170
4105112221
27142714
10_1007_s00415_016_8127_y
Genre Journal Article
GeographicLocations Netherlands
San Francisco California
California
United Kingdom--UK
United States--US
GeographicLocations_xml – name: San Francisco California
– name: California
– name: Netherlands
– name: United Kingdom--UK
– name: United States--US
GrantInformation_xml – fundername: Stichting MS Research
  grantid: personal travel grant
  funderid: http://dx.doi.org/10.13039/501100003000
– fundername: ;
  grantid: personal travel grant
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7U
Z81
Z82
Z83
Z87
Z8O
Z8U
Z8V
Z8W
Z91
Z92
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c503t-bb1a8a9f937f2c53f7fee44fc84888c496d78f763d28b05814af890e04908cd83
IEDL.DBID U2A
ISSN 0340-5354
1432-1459
IngestDate Thu Aug 21 13:59:19 EDT 2025
Thu Aug 07 14:59:33 EDT 2025
Sun Aug 24 04:08:51 EDT 2025
Fri Jul 25 02:03:04 EDT 2025
Wed Feb 19 02:03:56 EST 2025
Tue Jul 01 01:31:21 EDT 2025
Thu Apr 24 22:51:13 EDT 2025
Fri Feb 21 02:41:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Retina
Multiple sclerosis
Optical coherence tomography
RNFL
Neurodegeneration
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c503t-bb1a8a9f937f2c53f7fee44fc84888c496d78f763d28b05814af890e04908cd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s00415-016-8127-y
PMID 27142714
PQID 1800606647
PQPubID 47196
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4929170
proquest_miscellaneous_1808727466
proquest_miscellaneous_1801426957
proquest_journals_1800606647
pubmed_primary_27142714
crossref_citationtrail_10_1007_s00415_016_8127_y
crossref_primary_10_1007_s00415_016_8127_y
springer_journals_10_1007_s00415_016_8127_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-07-01
PublicationDateYYYYMMDD 2016-07-01
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationSubtitle Official Journal of the European Neurological Society
PublicationTitle Journal of neurology
PublicationTitleAbbrev J Neurol
PublicationTitleAlternate J Neurol
PublicationYear 2016
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Dalton, Chard, Davies, Miszkiel, Altmann, Fernando (CR3) 2004; 127
Schippling, Balk, Costello, Albrecht, Balcer, Calabresi (CR29) 2014; 21
Martinez-Lapiscina, Sanchez-Dalmau, Fraga-Pumar, Ortiz-Perez, Tercero-Uribe, Torres-Torres (CR9) 2014; 20
Trapp, Nave (CR1) 2008; 31
Green, McQuaid, Hauser, Allen, Lyness (CR20) 2010; 133
Kurtzke (CR26) 1983; 33
Oberwahrenbrock, Ringelstein, Jentschke, Deuschle, Klumbies, Bellmann-Strobl (CR23) 2013; 19
Gelfand, Nolan, Schwartz, Graves, Green (CR34) 2012; 135
Gabilondo, Martinez-Lapiscina, Fraga-Pumar, Ortiz-Perez, Torres-Torres, Andorra (CR38) 2015; 77
Huhn, Lammer, Oberwahrenbrock, Lammer, Waschbisch, Gosar (CR24) 2014; 22
Burggraaff, Trieu, de Vries-Knoppert, Balk, Petzold (CR30) 2014; 55
Costello (CR8) 2013; 2013
Albrecht, Ringelstein, Muller, Keser, Dietlein, Lappas (CR11) 2012; 18
Trip, Schlottmann, Jones, Altmann, Garway-Heath, Thompson (CR17) 2005; 58
Lublin, Reingold (CR25) 1996; 46
Young, Brandt, Petzold, Reitz, Lintze, Paul (CR22) 2013; 20
Costello, Hodge, Pan, Freedman, DeMeulemeester (CR31) 2009; 281
Balk, Twisk, Steenwijk, Daams, Tewarie, Killestein (CR10) 2014; 85
Petzold, Wattjes, Costello, Flores-Rivera, Fraser, Fujihara (CR27) 2014; 10
Narayanan, Cheng, Bonem, Saenz, Tang, Frishman (CR32) 2014; 20
Fisher, Lee, Nakamura, Rudick (CR6) 2008; 64
Saidha, Sotirchos, Ibrahim, Crainiceanu, Gelfand, Sepah (CR35) 2012; 11
Sakai, Feller, Galetta, Galetta, Balcer (CR15) 2011; 31
Tatrai, Simo, Iljicsov, Nemeth, Debuc, Somfai (CR14) 2012; 7
Syc, Saidha, Newsome, Ratchford, Levy, Ford (CR37) 2012; 135
Talman, Bisker, Sackel, Long, Galetta, Ratchford (CR18) 2010; 67
Fisniku, Chard, Jackson, Anderson, Altmann, Miszkiel (CR7) 2008; 64
Gabilondo, Martinez-Lapiscina, Martinez-Heras, Fraga-Pumar, Llufriu, Ortiz (CR12) 2014; 75
Saidha, Al-Louzi, Ratchford, Bhargava, Oh, Newsome (CR33) 2015
Sepulcre, Murie-Fernandez, Salinas-Alaman, Garcia-Layana, Bejarano, Villoslada (CR16) 2007; 68
Henderson, Trip, Schlottmann, Altmann, Garway-Heath, Plant (CR19) 2010; 257
Saidha, Sotirchos, Oh, Syc, Seigo, Shiee (CR13) 2013; 70
Gelfand, Goodin, Boscardin, Nolan, Cuneo, Green (CR21) 2012; 7
De, Matthews, Filippi, Agosta, De, Bartolozzi (CR4) 2003; 60
Petzold, Galimberti, Scaroini (CR2) 2014
Calabrese, Gallo (CR5) 2009; 15
Balk, Petzold (CR28) 2013; 54
Petzold, de Boer, Schippling, Vermersch, Kardon, Green (CR36) 2010; 9
JM Gelfand (8127_CR21) 2012; 7
S Saidha (8127_CR33) 2015
CM Dalton (8127_CR3) 2004; 127
LS Talman (8127_CR18) 2010; 67
AJ Green (8127_CR20) 2010; 133
E Fisher (8127_CR6) 2008; 64
K Huhn (8127_CR24) 2014; 22
F Costello (8127_CR31) 2009; 281
SN De (8127_CR4) 2003; 60
I Gabilondo (8127_CR12) 2014; 75
J Sepulcre (8127_CR16) 2007; 68
JF Kurtzke (8127_CR26) 1983; 33
S Saidha (8127_CR35) 2012; 11
E Tatrai (8127_CR14) 2012; 7
BD Trapp (8127_CR1) 2008; 31
A Petzold (8127_CR27) 2014; 10
A Petzold (8127_CR2) 2014
F Costello (8127_CR8) 2013; 2013
P Albrecht (8127_CR11) 2012; 18
LJ Balk (8127_CR28) 2013; 54
LJ Balk (8127_CR10) 2014; 85
A Petzold (8127_CR36) 2010; 9
RE Sakai (8127_CR15) 2011; 31
SB Syc (8127_CR37) 2012; 135
APD Henderson (8127_CR19) 2010; 257
S Schippling (8127_CR29) 2014; 21
E Martinez-Lapiscina (8127_CR9) 2014; 20
I Gabilondo (8127_CR38) 2015; 77
S Saidha (8127_CR13) 2013; 70
LK Fisniku (8127_CR7) 2008; 64
M Calabrese (8127_CR5) 2009; 15
SA Trip (8127_CR17) 2005; 58
T Oberwahrenbrock (8127_CR23) 2013; 19
MC Burggraaff (8127_CR30) 2014; 55
D Narayanan (8127_CR32) 2014; 20
KL Young (8127_CR22) 2013; 20
FD Lublin (8127_CR25) 1996; 46
JM Gelfand (8127_CR34) 2012; 135
23041237 - Lancet Neurol. 2012 Nov;11(11):963-72
23633680 - Invest Ophthalmol Vis Sci. 2013 Apr 30;54(4):3045
24639478 - Mult Scler. 2014 Sep;20(10):1331-41
24948688 - Mult Scler. 2015 Feb;21(2):163-70
18570297 - Ann Neurol. 2008 Sep;64(3):247-54
19303605 - J Neurol Sci. 2009 Jun 15;281(1-2):74-9
25559267 - Ann Neurol. 2015 Mar;77(3):517-28
24474822 - J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):782-9
18558855 - Annu Rev Neurosci. 2008;31:247-69
25002105 - Nat Rev Neurol. 2014 Aug;10(8):447-58
20143110 - J Neurol. 2010 Jul;257(7):1083-91
22666330 - PLoS One. 2012;7(5):e36847
12682324 - Neurology. 2003 Apr 8;60(7):1157-62
16075460 - Ann Neurol. 2005 Sep;58(3):383-91
23702433 - Mult Scler. 2013 Dec;19(14):1887-95
25104178 - Eur J Neurol. 2015 Jan;22(1):86-92
25013155 - Mult Scler. 2014 Nov;20(13):1678-85
14998914 - Brain. 2004 May;127(Pt 5):1101-7
23318513 - JAMA Neurol. 2013 Jan;70(1):34-43
20723847 - Lancet Neurol. 2010 Sep;9(9):921-32
8780061 - Neurology. 1996 Apr;46(4):907-11
22292076 - PLoS One. 2012;7(1):e30922
22539259 - Brain. 2012 Jun;135(Pt 6):1786-93
22089500 - J Neuroophthalmol. 2011 Dec;31(4):362-73
22006982 - Brain. 2012 Feb;135(Pt 2):521-33
24398089 - Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):952-61
22389411 - Mult Scler. 2012 Oct;18(10):1422-9
6685237 - Neurology. 1983 Nov;33(11):1444-52
17470751 - Neurology. 2007 May 1;68(18):1488-94
24288622 - ISRN Neurol. 2013 Nov 06;2013:134858
19667021 - Mult Scler. 2009 Aug;15(8):933-41
20410146 - Brain. 2010 Jun;133(Pt 6):1591-601
26190464 - Ann Neurol. 2015 Nov;78(5):801-13
23369013 - Eur J Neurol. 2013 May;20(5):803-11
18661561 - Ann Neurol. 2008 Sep;64(3):255-65
24114885 - Ann Neurol. 2014 Jan;75(1):98-107
20517936 - Ann Neurol. 2010 Jun;67(6):749-60
References_xml – volume: 85
  start-page: 782
  issue: 7
  year: 2014
  end-page: 789
  ident: CR10
  article-title: A dam for retrograde axonal degeneration in multiple sclerosis?
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2013-306902
– volume: 11
  start-page: 963
  issue: 11
  year: 2012
  end-page: 972
  ident: CR35
  article-title: Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(12)70213-2
– volume: 68
  start-page: 1488
  issue: 18
  year: 2007
  end-page: 1494
  ident: CR16
  article-title: Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000260612.51849.ed
– start-page: 227
  year: 2014
  end-page: 245
  ident: CR2
  article-title: Neurodegeneration and multiple sclerosis
  publication-title: Neurodegenerative diseases
  doi: 10.1007/978-1-4471-6380-0_14
– volume: 31
  start-page: 247
  year: 2008
  end-page: 269
  ident: CR1
  article-title: Multiple sclerosis: an immune or neurodegenerative disorder?
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev.neuro.30.051606.094313
– volume: 64
  start-page: 255
  issue: 3
  year: 2008
  end-page: 265
  ident: CR6
  article-title: Gray matter atrophy in multiple sclerosis: a longitudinal study
  publication-title: Ann Neurol
  doi: 10.1002/ana.21436
– volume: 281
  start-page: 74
  issue: 1–2
  year: 2009
  end-page: 79
  ident: CR31
  article-title: Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2009.02.354
– volume: 127
  start-page: 1101
  year: 2004
  end-page: 1107
  ident: CR3
  article-title: Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
  publication-title: Brain
  doi: 10.1093/brain/awh126
– volume: 15
  start-page: 933
  issue: 8
  year: 2009
  end-page: 941
  ident: CR5
  article-title: Magnetic resonance evidence of cortical onset of multiple sclerosis
  publication-title: Mult Scler
  doi: 10.1177/1352458509106510
– volume: 22
  start-page: 86
  issue: 1
  year: 2014
  end-page: 92
  ident: CR24
  article-title: Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage
  publication-title: Eur J Neurol
  doi: 10.1111/ene.12532
– year: 2015
  ident: CR33
  article-title: Optical coherence tomography reflects brain atrophy in MS: a four year study
  publication-title: Ann Neurol
– volume: 20
  start-page: 1331
  issue: 10
  year: 2014
  end-page: 1341
  ident: CR32
  article-title: Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis
  publication-title: Mult Scler
  doi: 10.1177/1352458514523498
– volume: 257
  start-page: 1083
  issue: 7
  year: 2010
  end-page: 1091
  ident: CR19
  article-title: A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis
  publication-title: J Neurol
  doi: 10.1007/s00415-010-5467-x
– volume: 20
  start-page: 803
  issue: 5
  year: 2013
  end-page: 811
  ident: CR22
  article-title: Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis
  publication-title: Eur J Neurol
  doi: 10.1111/ene.12070
– volume: 54
  start-page: 3045
  issue: 4
  year: 2013
  ident: CR28
  article-title: Influence of the eye-tracking-based follow-up function in retinal nerve fiber layer thickness using fourier-domain optical coherence tomography
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.13-12073
– volume: 70
  start-page: 34
  issue: 1
  year: 2013
  end-page: 43
  ident: CR13
  article-title: Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.573
– volume: 20
  start-page: 1678
  issue: 13
  year: 2014
  end-page: 1685
  ident: CR9
  article-title: The visual pathway as a model to understand brain damage in multiple sclerosis
  publication-title: Mult Scler
  doi: 10.1177/1352458514542862
– volume: 133
  start-page: 1591
  issue: Pt 6
  year: 2010
  end-page: 1601
  ident: CR20
  article-title: Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
  publication-title: Brain
  doi: 10.1093/brain/awq080
– volume: 55
  start-page: 952
  issue: 2
  year: 2014
  end-page: 961
  ident: CR30
  article-title: The clinical spectrum of microcystic macular edema
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.13-12912
– volume: 19
  start-page: 1887
  issue: 14
  year: 2013
  end-page: 1895
  ident: CR23
  article-title: Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
  publication-title: Mult Scler
  doi: 10.1177/1352458513489757
– volume: 10
  start-page: 447
  issue: 8
  year: 2014
  end-page: 458
  ident: CR27
  article-title: The investigation of acute optic neuritis: a review and proposed protocol
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2014.108
– volume: 2013
  start-page: 134858
  year: 2013
  ident: CR8
  article-title: The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis
  publication-title: ISRN Neurol
– volume: 21
  start-page: 163
  issue: 2
  year: 2014
  end-page: 170
  ident: CR29
  article-title: Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
  publication-title: Mult Scler
  doi: 10.1177/1352458514538110
– volume: 46
  start-page: 907
  issue: 4
  year: 1996
  end-page: 911
  ident: CR25
  article-title: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
  publication-title: Neurology
  doi: 10.1212/WNL.46.4.907
– volume: 67
  start-page: 749
  issue: 6
  year: 2010
  end-page: 760
  ident: CR18
  article-title: Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
  publication-title: Ann Neurol
– volume: 77
  start-page: 517
  issue: 3
  year: 2015
  end-page: 528
  ident: CR38
  article-title: Dynamics of retinal injury after acute optic neuritis
  publication-title: Ann Neurol
  doi: 10.1002/ana.24351
– volume: 18
  start-page: 1422
  issue: 10
  year: 2012
  end-page: 1429
  ident: CR11
  article-title: Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography
  publication-title: Mult Scler
  doi: 10.1177/1352458512439237
– volume: 60
  start-page: 1157
  issue: 7
  year: 2003
  end-page: 1162
  ident: CR4
  article-title: Evidence of early cortical atrophy in MS: relevance to white matter changes and disability
  publication-title: Neurology 8
  doi: 10.1212/01.WNL.0000055926.69643.03
– volume: 75
  start-page: 98
  issue: 1
  year: 2014
  end-page: 107
  ident: CR12
  article-title: Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.24030
– volume: 58
  start-page: 383
  issue: 3
  year: 2005
  end-page: 391
  ident: CR17
  article-title: Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis
  publication-title: Ann Neurol
  doi: 10.1002/ana.20575
– volume: 7
  start-page: e30922
  issue: 1
  year: 2012
  ident: CR14
  article-title: In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030922
– volume: 33
  start-page: 1444
  issue: 11
  year: 1983
  end-page: 1452
  ident: CR26
  article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– volume: 135
  start-page: 1786
  issue: Pt 6
  year: 2012
  end-page: 1793
  ident: CR34
  article-title: Microcystic macular oedema in multiple sclerosis is associated with disease severity
  publication-title: Brain
  doi: 10.1093/brain/aws098
– volume: 135
  start-page: 521
  issue: Pt 2
  year: 2012
  end-page: 533
  ident: CR37
  article-title: Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis
  publication-title: Brain
  doi: 10.1093/brain/awr264
– volume: 9
  start-page: 921
  issue: 9
  year: 2010
  end-page: 932
  ident: CR36
  article-title: Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70168-X
– volume: 31
  start-page: 362
  issue: 4
  year: 2011
  end-page: 373
  ident: CR15
  article-title: Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection
  publication-title: J Neuroophthalmol
  doi: 10.1097/WNO.0b013e318238937f
– volume: 7
  start-page: e36847
  issue: 5
  year: 2012
  ident: CR21
  article-title: Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036847
– volume: 64
  start-page: 247
  issue: 3
  year: 2008
  end-page: 254
  ident: CR7
  article-title: Gray matter atrophy is related to long-term disability in multiple sclerosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.21423
– volume: 54
  start-page: 3045
  issue: 4
  year: 2013
  ident: 8127_CR28
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.13-12073
– volume: 64
  start-page: 247
  issue: 3
  year: 2008
  ident: 8127_CR7
  publication-title: Ann Neurol
  doi: 10.1002/ana.21423
– volume: 20
  start-page: 1331
  issue: 10
  year: 2014
  ident: 8127_CR32
  publication-title: Mult Scler
  doi: 10.1177/1352458514523498
– volume: 127
  start-page: 1101
  year: 2004
  ident: 8127_CR3
  publication-title: Brain
  doi: 10.1093/brain/awh126
– volume: 20
  start-page: 1678
  issue: 13
  year: 2014
  ident: 8127_CR9
  publication-title: Mult Scler
  doi: 10.1177/1352458514542862
– volume: 33
  start-page: 1444
  issue: 11
  year: 1983
  ident: 8127_CR26
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– year: 2015
  ident: 8127_CR33
  publication-title: Ann Neurol
  doi: 10.1002/ana.24487
– volume: 15
  start-page: 933
  issue: 8
  year: 2009
  ident: 8127_CR5
  publication-title: Mult Scler
  doi: 10.1177/1352458509106510
– volume: 31
  start-page: 247
  year: 2008
  ident: 8127_CR1
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev.neuro.30.051606.094313
– start-page: 227
  volume-title: Neurodegenerative diseases
  year: 2014
  ident: 8127_CR2
  doi: 10.1007/978-1-4471-6380-0_14
– volume: 21
  start-page: 163
  issue: 2
  year: 2014
  ident: 8127_CR29
  publication-title: Mult Scler
  doi: 10.1177/1352458514538110
– volume: 75
  start-page: 98
  issue: 1
  year: 2014
  ident: 8127_CR12
  publication-title: Ann Neurol
  doi: 10.1002/ana.24030
– volume: 20
  start-page: 803
  issue: 5
  year: 2013
  ident: 8127_CR22
  publication-title: Eur J Neurol
  doi: 10.1111/ene.12070
– volume: 7
  start-page: e30922
  issue: 1
  year: 2012
  ident: 8127_CR14
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030922
– volume: 67
  start-page: 749
  issue: 6
  year: 2010
  ident: 8127_CR18
  publication-title: Ann Neurol
  doi: 10.1002/ana.22005
– volume: 70
  start-page: 34
  issue: 1
  year: 2013
  ident: 8127_CR13
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.573
– volume: 7
  start-page: e36847
  issue: 5
  year: 2012
  ident: 8127_CR21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036847
– volume: 281
  start-page: 74
  issue: 1–2
  year: 2009
  ident: 8127_CR31
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2009.02.354
– volume: 18
  start-page: 1422
  issue: 10
  year: 2012
  ident: 8127_CR11
  publication-title: Mult Scler
  doi: 10.1177/1352458512439237
– volume: 60
  start-page: 1157
  issue: 7
  year: 2003
  ident: 8127_CR4
  publication-title: Neurology 8
  doi: 10.1212/01.WNL.0000055926.69643.03
– volume: 22
  start-page: 86
  issue: 1
  year: 2014
  ident: 8127_CR24
  publication-title: Eur J Neurol
  doi: 10.1111/ene.12532
– volume: 46
  start-page: 907
  issue: 4
  year: 1996
  ident: 8127_CR25
  publication-title: Neurology
  doi: 10.1212/WNL.46.4.907
– volume: 85
  start-page: 782
  issue: 7
  year: 2014
  ident: 8127_CR10
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2013-306902
– volume: 55
  start-page: 952
  issue: 2
  year: 2014
  ident: 8127_CR30
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.13-12912
– volume: 2013
  start-page: 134858
  year: 2013
  ident: 8127_CR8
  publication-title: ISRN Neurol
  doi: 10.1155/2013/134858
– volume: 135
  start-page: 1786
  issue: Pt 6
  year: 2012
  ident: 8127_CR34
  publication-title: Brain
  doi: 10.1093/brain/aws098
– volume: 10
  start-page: 447
  issue: 8
  year: 2014
  ident: 8127_CR27
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2014.108
– volume: 133
  start-page: 1591
  issue: Pt 6
  year: 2010
  ident: 8127_CR20
  publication-title: Brain
  doi: 10.1093/brain/awq080
– volume: 58
  start-page: 383
  issue: 3
  year: 2005
  ident: 8127_CR17
  publication-title: Ann Neurol
  doi: 10.1002/ana.20575
– volume: 257
  start-page: 1083
  issue: 7
  year: 2010
  ident: 8127_CR19
  publication-title: J Neurol
  doi: 10.1007/s00415-010-5467-x
– volume: 77
  start-page: 517
  issue: 3
  year: 2015
  ident: 8127_CR38
  publication-title: Ann Neurol
  doi: 10.1002/ana.24351
– volume: 9
  start-page: 921
  issue: 9
  year: 2010
  ident: 8127_CR36
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70168-X
– volume: 19
  start-page: 1887
  issue: 14
  year: 2013
  ident: 8127_CR23
  publication-title: Mult Scler
  doi: 10.1177/1352458513489757
– volume: 31
  start-page: 362
  issue: 4
  year: 2011
  ident: 8127_CR15
  publication-title: J Neuroophthalmol
  doi: 10.1097/WNO.0b013e318238937f
– volume: 11
  start-page: 963
  issue: 11
  year: 2012
  ident: 8127_CR35
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(12)70213-2
– volume: 64
  start-page: 255
  issue: 3
  year: 2008
  ident: 8127_CR6
  publication-title: Ann Neurol
  doi: 10.1002/ana.21436
– volume: 135
  start-page: 521
  issue: Pt 2
  year: 2012
  ident: 8127_CR37
  publication-title: Brain
  doi: 10.1093/brain/awr264
– volume: 68
  start-page: 1488
  issue: 18
  year: 2007
  ident: 8127_CR16
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000260612.51849.ed
– reference: 24114885 - Ann Neurol. 2014 Jan;75(1):98-107
– reference: 8780061 - Neurology. 1996 Apr;46(4):907-11
– reference: 22539259 - Brain. 2012 Jun;135(Pt 6):1786-93
– reference: 16075460 - Ann Neurol. 2005 Sep;58(3):383-91
– reference: 20517936 - Ann Neurol. 2010 Jun;67(6):749-60
– reference: 23041237 - Lancet Neurol. 2012 Nov;11(11):963-72
– reference: 17470751 - Neurology. 2007 May 1;68(18):1488-94
– reference: 20410146 - Brain. 2010 Jun;133(Pt 6):1591-601
– reference: 26190464 - Ann Neurol. 2015 Nov;78(5):801-13
– reference: 24288622 - ISRN Neurol. 2013 Nov 06;2013:134858
– reference: 25559267 - Ann Neurol. 2015 Mar;77(3):517-28
– reference: 25104178 - Eur J Neurol. 2015 Jan;22(1):86-92
– reference: 23369013 - Eur J Neurol. 2013 May;20(5):803-11
– reference: 6685237 - Neurology. 1983 Nov;33(11):1444-52
– reference: 22389411 - Mult Scler. 2012 Oct;18(10):1422-9
– reference: 18661561 - Ann Neurol. 2008 Sep;64(3):255-65
– reference: 19667021 - Mult Scler. 2009 Aug;15(8):933-41
– reference: 22089500 - J Neuroophthalmol. 2011 Dec;31(4):362-73
– reference: 25013155 - Mult Scler. 2014 Nov;20(13):1678-85
– reference: 20723847 - Lancet Neurol. 2010 Sep;9(9):921-32
– reference: 19303605 - J Neurol Sci. 2009 Jun 15;281(1-2):74-9
– reference: 18570297 - Ann Neurol. 2008 Sep;64(3):247-54
– reference: 22006982 - Brain. 2012 Feb;135(Pt 2):521-33
– reference: 24474822 - J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):782-9
– reference: 22292076 - PLoS One. 2012;7(1):e30922
– reference: 20143110 - J Neurol. 2010 Jul;257(7):1083-91
– reference: 24948688 - Mult Scler. 2015 Feb;21(2):163-70
– reference: 18558855 - Annu Rev Neurosci. 2008;31:247-69
– reference: 22666330 - PLoS One. 2012;7(5):e36847
– reference: 24398089 - Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):952-61
– reference: 14998914 - Brain. 2004 May;127(Pt 5):1101-7
– reference: 25002105 - Nat Rev Neurol. 2014 Aug;10(8):447-58
– reference: 12682324 - Neurology. 2003 Apr 8;60(7):1157-62
– reference: 23702433 - Mult Scler. 2013 Dec;19(14):1887-95
– reference: 24639478 - Mult Scler. 2014 Sep;20(10):1331-41
– reference: 23633680 - Invest Ophthalmol Vis Sci. 2013 Apr 30;54(4):3045
– reference: 23318513 - JAMA Neurol. 2013 Jan;70(1):34-43
SSID ssj0008459
Score 2.503739
Snippet The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1323
SubjectTerms Adult
Atrophy
Atrophy - diagnostic imaging
Atrophy - etiology
Axons - pathology
Female
Humans
Longitudinal Studies
Male
Medicine
Medicine & Public Health
Middle Aged
Multiple sclerosis
Multiple Sclerosis - complications
Nervous system
Neurology
Neuroradiology
Neurosciences
Optics
Original Communication
Patients
Retina - diagnostic imaging
Retina - pathology
Retinal Neurons - pathology
Time Factors
Tomography
Tomography, Optical Coherence
Visual Pathways - diagnostic imaging
SummonAdditionalLinks – databaseName: Proquest Health and Medical Complete
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dSxwxEB-qBfGl9MPqWltS6FMlNNmdbLJ9KUUqIlx98IR7W3aTjR7IntY70P--mdzu1qt4DwtZMoEkM8lMMpPfAHxpMqyUMuGkqtFz9FrxwhvJHQbtZL2zGJGYRr_zkws8nahJd-F214VV9nti3KjdzNId-TdpCDokz1H_uLnllDWKvKtdCo0NeEnQZRTSpSfDgUsYjMnSRIaCq0xh79UUSxBRSWFrOQ8qTvOHVb30xNh8GjP5n-M06qPj1_CqMyTZzyXn38CLpn0LW6POVf4OTseUr-uSzTyjh4pEG7ErqVC1jlX3sXgdOsOmLRudf2dV-KP0RQsXyc-Oxiyiz-7AxfGv8dEJ7xIncKtENud1LStTFT6YHj61KvPaNw2ityYsV2OxyJ02PuwsLjW1UEZi5U0hmugFtM5k72GznbXNHjCtdV1ol-beOCy0rNNCohPSojC1sUUCop-20nao4pTc4roc8JDjTJcUSUYzXT4k8HVocrOE1FhHfNDzouxW1135TxYS-DxUh3VBzo6qbWaLSCPpma5aT2OC_YZ5nsDukr1Dj1IdmocvAb3C-IGAcLlXa9rpVcTnxmBySi0SOOxF5FHXnxvo_vqBfoDtlIQ1BgofwOb8z6L5GMyhef0pyvxfEcQExQ
  priority: 102
  providerName: ProQuest
Title Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
URI https://link.springer.com/article/10.1007/s00415-016-8127-y
https://www.ncbi.nlm.nih.gov/pubmed/27142714
https://www.proquest.com/docview/1800606647
https://www.proquest.com/docview/1801426957
https://www.proquest.com/docview/1808727466
https://pubmed.ncbi.nlm.nih.gov/PMC4929170
Volume 263
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZeyr7rtQsq7GlDINmnD_ctC-lKS7qxJZA9GVuy2kJxyprA-t9PUmyzrFthD8aydTKyTtKduLvfAbyrMyyF0P6kqtBRdErQ3GlOLXrpZJw1GJGYJufyZIanczFv47hvO2_3ziQZd-o-2C1AQwVHM0m9UFL0bgt2RDi6-0k8S4f99qsxZkhjGTIqMoGdKfNvn9gURvc0zPuOkn9YS6MQOn4Ku632SIZrdj-DR3XzHB5PWvv4CzidhiRdF2ThSIhODLQRsDIUysaS8mcsXvvOkKuGTL4dkdI_hZxFKxvJP4-mJELOvoTZ8Xg6OqFttgRqBMuWtKp4qcvceX3DpUZkTrm6RnRG-zWqDebSKu38dmJTXTGhOZZO56yOpj9jdfYKtptFU-8BUUpVubKpdNpirniV5hwt4waZrrTJE2DdsBWmhRIPGS2uix4EOY50EdzHwkgXdwm875vcrHE0HiI-6HhRtEvqtuA6YMdIiSqBw77aL4Zg4SiberGKNDzE5oqHabRX2lDKBF6v2dv3KFW-ub8SUBuM7wkCGPdmTXN1GUG50euZXLEEPnRT5Leu_-tH3_wX9T48ScPcjc7CB7C9_LGq33qVaFkNYEvN1QB2hp--n439_eP4_MtX_3YkR4O4PH4BZkwGwg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwEF5BVOxnHDhJCUFptH7sg2Eq9hcSOoVKVLXRXsH-K34jtPGCp2FsPkRx5HPkx4xlnxt8APK0SLIRQ7qQq0VK0UtDMKk4NOu2krdEYkJhG43R4iHtH4mgNfnV3YXxYZbcnho3aTLX_R77JlYcOSVOUr0-_UZ81yntXuxQaDVvsV4sf7sh29mr3nVvfZ3G8sz3ZGtI2qwDVgiUzWpa8UEVmnV62sRaJlbaqEK1WjpeVxiw1UlkndiZWJROKY2FVxqrgItNGJe67l2AdE3eUGcD62-3xh4_93q8wpGdjCTIqEoGdH5U1sKXcB8ql1ClVSRfLmvCceXs-SvMfV23QgDvX4VprupI3Da_dgLWqvgmXR61z_hbsTXyGsC9kaom_GulpA1qmLxS1IcXPUDxxnSHHNRl9ekkK9-YTJs1NIH-_NSEB7_Y2HF7IpN6BQT2tq3tApJRlJk2cWmUwk7yMM46GcY1MlUpnEbBu2nLd4pj7dBoneY_AHGY697FrfqbzRQTP-yanDYjHKuKNbi3yVp7P8j_cF8GTvtpJonevFHU1nQca7i8Gi9U0ylmMmKYR3G2Wt-9RLF1z90Qglxa-J_BI4Ms19fHXgAiOzsjlkkXwomORv7r-v4HeXz3Qx3BlOBkd5Ae74_0HcDX2jBvClDdgMPs-rx46Y2xWPmolgMDnixa634PUQsg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9qheJL8dutVSPoixKa7E42WUFEWo9-eFXwCve27iabtlD2qr2jvX_Nv84k-6Fn8d76sJAlkyUfM5nJzuQ3AK-qBAshlDupSrQUrRQ0s4pTg047aWs0BiSm4WG6e4T7YzFegV_dXRgfVtntiWGjNhPt_5FvceWhQ9IU5ZZtwyK-7gw-nP-gPoOU97R26TQaFjmo5pfu-Hbxfm_HrfXrOB58Gm3v0jbDANWCJVNalrxQRWadjraxFomVtqoQrVaOr5XGLDVSWSeCJlYlE4pjYVXGquAu00Yl7ru34LZMBPcyJsf9YY8pDInaWIKMikRg51FlDYAp9yFzKXXqVdL5ok68Zuhej9f8x2kbdOHgLqy3Riz52HDdPVip6vuwNmzd9A9gf-RzhR2TiSX-kqSnDbiZvlDUhhRXoXjmOkNOazL89o4U7s2nTpqZQP5le0QC8u1DOLqRKX0Eq_Wkrp4AkVKWmTRxapXBTPIyzjgaxjUyVSqdRcC6act1i2juE2uc5T0Wc5jp3Eex-ZnO5xG86ZucN3Aey4g3u7XIW8m-yP_wYQQv-2onk97RUtTVZBZouL8iLJbTKGc7YppG8LhZ3r5HsXTN3ROBXFj4nsBjgi_W1KcnARscnbnLJYvgbccif3X9fwPdWD7QF7DmRC3_vHd48BTuxJ5vQ7zyJqxOf86qZ84qm5bPA_sT-H7T8vYbKTdFmA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Timing+of+retinal+neuronal+and+axonal+loss+in+MS%3A+a+longitudinal+OCT+study&rft.jtitle=Journal+of+neurology&rft.au=Balk%2C+Lisanne+J.&rft.au=Cruz-Herranz%2C+Andr%C3%A9s&rft.au=Albrecht%2C+Philipp&rft.au=Arnow%2C+Sam&rft.date=2016-07-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0340-5354&rft.eissn=1432-1459&rft.volume=263&rft.issue=7&rft.spage=1323&rft.epage=1331&rft_id=info:doi/10.1007%2Fs00415-016-8127-y&rft.externalDocID=10_1007_s00415_016_8127_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon